Humanity's fight against cancer is expected to continue for years to come. Scientists across the globe are constantly inventing novel synthetic methods for the rapid and efficient production of anticancer therapeutics. However, the chemical synthesis of one such powerful anticancer drug—vinblastine—poses major challenges, owing to its complex three-dimensional structure. Vinblastine is a heterodimer of the chemical compounds catharanthine and vindoline.
